Desitin Arzneimittel Gmbh

Desitin Arzneimittel Gmbh logo
🇳🇴Norway
Ownership
Private
Established
1919-01-01
Employees
251
Market Cap
-
Website
http://www.desitin.de

Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets

First Posted Date
2024-01-19
Last Posted Date
2024-01-23
Lead Sponsor
Desitin Arzneimittel GmbH
Target Recruit Count
22
Registration Number
NCT06214130
Locations
🇨🇦

Biopharma Services INC, Toronto, Canada

Bioavailability and Food Effect of Sodium Valproate Minitablets in Healthy Subjects.

Phase 1
Completed
Conditions
Interventions
First Posted Date
2024-01-18
Last Posted Date
2024-01-22
Lead Sponsor
Desitin Arzneimittel GmbH
Target Recruit Count
28
Registration Number
NCT06211283
Locations
🇨🇦

Biopharma Services INC, Toronto, Canada

Single-dose, Two-way Crossover Bioequivalence of Lamotrigine in Healthy Male Volunteers Under Fasting Conditions

Phase 1
Completed
Conditions
Interventions
First Posted Date
2024-01-10
Last Posted Date
2024-01-10
Lead Sponsor
Desitin Arzneimittel GmbH
Target Recruit Count
24
Registration Number
NCT06199791
Locations
🇨🇦

Biopharma Services INC, Toronto, Canada

Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)

Phase 2
Completed
Conditions
Interventions
First Posted Date
2022-02-11
Last Posted Date
2023-11-29
Lead Sponsor
Desitin Arzneimittel GmbH
Target Recruit Count
298
Registration Number
NCT05236842
Locations
🇧🇪

Pneumocare SRL, Namur, Belgium

Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration

First Posted Date
2014-04-17
Last Posted Date
2014-04-17
Lead Sponsor
Desitin Arzneimittel GmbH
Target Recruit Count
12
Registration Number
NCT02116465
Locations
🇧🇬

Department of Clinical Pharmacology, Sofia, Bulgaria

PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy

Completed
Conditions
Interventions
First Posted Date
2012-01-27
Last Posted Date
2016-01-29
Lead Sponsor
Desitin Arzneimittel GmbH
Target Recruit Count
908
Registration Number
NCT01519856
Locations
🇩🇪

Dr. Erich Scholz, Boeblingen, Baden-Wuertemberg, Germany

ESOXC-ER Efficacy and Safety of an Extended Release (ER) Formulation of Oxcarbazepine (Apydan Extent) in Epileptic Patients

Completed
Conditions
First Posted Date
2010-03-15
Last Posted Date
2013-03-01
Lead Sponsor
Desitin Arzneimittel GmbH
Target Recruit Count
225
Registration Number
NCT01086501
Locations
🇩🇪

Dr. Stephan Arnold, Munich, Bavaria, Germany

Valproate Sustained Release Minitablets (Orfiril(R) Long) Once Daily in the Evening

Completed
Conditions
Interventions
First Posted Date
2009-03-27
Last Posted Date
2009-05-20
Lead Sponsor
Desitin Arzneimittel GmbH
Target Recruit Count
82
Registration Number
NCT00870688

SEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson's Disease (PIR-002/K)

Completed
Conditions
Interventions
First Posted Date
2008-08-04
Last Posted Date
2009-02-25
Lead Sponsor
Desitin Arzneimittel GmbH
Target Recruit Count
750
Registration Number
NCT00727727
Locations
🇩🇪

Medical Practice for Neurology, Wedel, Germany

© Copyright 2024. All Rights Reserved by MedPath